French medical technology company EDAP secures €36 million credit facility from EIB to advance prostate cancer and endometriosis non-invasive treatment
France, Oct. 20 -- EDAP TMS SA, a global leader in robotic, energy-based therapeutic technologies, today announced that it has entered into a €36 million multi-tranche credit facility (the "Credit Facility") with the European Investment Bank (EIB). The financing is backed by a guarantee by InvestEU, the European Commission's program to sustain innovation.Proceeds from the financing will be used to support the continued global expansion of the Company's Focal One(R) Robotic High-Intensity Focused Ultrasound (HIFU) platform. The funds will also accelerate the development of new clinical indications for the Company's innovative HIFU technology.EDAP expects to draw the first tranche of €11 million under the Credit Facility in the fo...
To read the full article or to get the complete feed from this publication, please
Contact Us.